semaglutide compounded with b12 B12: A Dual Approach to Weight Loss and Energy JustAnswer
Description
GLP-1 therapies may help reduce antipsychotic-associated weight gain and metabolic risk in patients with serious mental illness.
Heres my storyand the science behind why sustainable lifestyle changes still matter.
We just published data showing that members on GLP-1 therapy who received concurrent nutrition support saved $168 PMPM more than matched members on GLP-1s alone
Retention of glucagon function is required to achieve such an advantage over GLP-1 monotherapy
Many other drugmakers are attempting to break this duopoly, but this may not happen anytime soon.
